Verkuil, Arie Hans

Lade...
Profilbild
E-Mail-Adresse
Geburtsdatum
Projekt
Organisationseinheiten
Berufsbeschreibung
Nachname
Verkuil
Vorname
Arie Hans
Name
Verkuil, Arie Hans

Suchergebnisse

Gerade angezeigt 1 - 10 von 40
  • Publikation
    SMEs talk - startups walk - How startups can benefit from the use of a digital maturity model for SMEs as part of digital transformation
    (Springer, 2024) Klotz, Patrick; Eisenbart, Barbara; Verkuil, Arie Hans [in: Start-up cultures in times of global crises. Sustainable and innovative approaches]
    While digital transformation has been widely implemented in large corporations, there is a big potential for startups and SMEs which are lacking behind in utilizing this opportunity. This paper aims to raise awareness among startups and SMEs about digital transformation by developing a digital maturity model adopted especially for international distributed work. The model serves as a framework for startups and SMEs to understand which dimensions influence and are important for digital transformation, and what specific questions are relevant for each of the dimensions.
    04A - Beitrag Sammelband
  • Publikation
    Religious roots of the concept of mindfulness as a reference point for ethical leadership
    (Springer, 2022) Verkuil, Arie Hans; Schulte, Volker; Steinebach, Christoph; Veth, Klaske [in: Mindful leadership in practice tradition leads to the future]
    04A - Beitrag Sammelband
  • Publikation
    Case biogas and solar service provider
    (edition gesowip, 2021) Syed, Obed Rashdi; Milow, Uta; Milow, Uta; Reineke, Rolf-Dieter; Verkuil, Arie Hans [in: International entrepreneurship and innovation]
    04A - Beitrag Sammelband
  • Publikation
    Religiöse Wurzeln des Achtsamkeitskonzepts als Bezugspunkt für ethische Führung
    (Schäffer-Poeschel, 2021) Verkuil, Arie Hans; Schulte, Volker; Steinebach, Christoph; Veth, Klaske [in: Achtsame Führung. Schlüsselelemente für das Management im 21. Jahrhundert]
    Der Artikel reflektiert die buddhistische, hinduistische und christliche Tradition des Achtsamkeitskonzepts als Bezugspunkt für ethische Führung.
    04A - Beitrag Sammelband
  • Publikation
    Case Roodee LMS
    (edition gesowip, 2021) Kunsapsak, Chutikarn; Milow, Uta; Milow, Uta; Reineke, Rolf-Dieter; Verkuil, Arie Hans [in: International entrepreneurship and innovation]
    Case Study, innovative learning management platform, Malaysia
    04A - Beitrag Sammelband
  • Publikation
    Case Brextor
    (edition gesowip, 2021) Reineke, Rolf-Dieter; Portmann, Alois; Reber, Marcel; Milow, Uta; Reineke, Rolf-Dieter; Verkuil, Arie Hans [in: International entrepreneurship and innovation]
    04A - Beitrag Sammelband
  • Publikation
    Case WAWTA (app for the blind)
    (edition gesowip, 2021) Raksasakul, Punchaya; Milow, Uta; Milow, Uta; Reineke, Rolf-Dieter; Verkuil, Arie Hans [in: International entrepreneurship and innovation]
    04A - Beitrag Sammelband
  • Publikation
    Case Jinn-Bot Robotics Design GmbH
    (edition gesowip, 2021) Reineke, Rolf-Dieter; Seeberger, Roger; Milow, Uta; Reineke, Rolf-Dieter; Verkuil, Arie Hans [in: International Entrepreneurship and Innovation]
    04A - Beitrag Sammelband
  • Publikation
    Case study essento
    (edition gesowip, 2020) Meyer, Rolf; Verkuil, Arie Hans; Aeschbacher, Marc [in: Start-ups. Aktuelle Case Studies für den Unterricht]
    04A - Beitrag Sammelband
  • Publikation
    Case Study "Perseo Pharma"
    (edition gesowip, 2020) Kabous, Laila; Verkuil, Arie Hans; Meyer, Rolf; Aeschbacher, Marc [in: Start-ups. Aktuelle Case Studies für den Unterricht]
    Founded in 2019, Perseo Pharma is a preclinical-stage biotech company with a unique asset for the development of enzyme therapies. Perseo Pharma possesses an innovative and proprietary enzyme shielding technology. Founded as independent spin-off of INOFEA AG, the company focuses on therapeutic enzymes for the treatment of cancer and rare genetic diseases. Over the past three decades, 30 therapeutic enzymes have been approved by EMA and FDA generating yearly 40bn. Therapeutic enzymes address a wide variety of indications, ranging from rare genetic diseases (enzyme replacement therapies) to oncology (key tumor-element depletion therapies). This offers biotech companies different opportunities and application fields for further development of enzyme therapeutics. The goal of this research is to analyze the case based on the 7-key model and provide recommendations on the financing opportunities available for Perseo pharma.
    04A - Beitrag Sammelband